Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

781308

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Accountable Care Organisations: Greater Manchester
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations he has received on the effect on plans for accountable care organisations in Manchester of NHS VAT arrangements agreed with HM Revenue and Customs; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	110509
answer	answer is ministerial correction date of answer 08/11/2017 answer text <p>National Health Service organisations are responsible for deciding locally the most appropriate structures and arrangements they need to put in place to deliver services to their patients within available resources, meeting any tax liabilities that may arise and always ensuring they are working within the existing tax framework as applicable in the United Kingdom.</p><p> </p><p>This principle applies to the commissioning and delivery of the Accountable Care Models Contract (ACO contract). The Department expects local health economies, particularly providers, to consider carefully the VAT implications of any organisational form they choose to develop for the purpose of holding an ACO contract.</p><p> </p><p>An initial high level meeting between all affected parties was hosted by the Department on 13 July 2017.</p><p> </p><p>The Department and NHS England officials continue to work with Manchester and HM Revenue and Customs to assess the issues arising from the development of a Manchester ACO, including the VAT implications.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/11/2017 17:10:05 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

781309

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Transport
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, which categories of claimants of universal credit are entitled to claim help with healthcare travel costs; and whether he plans to change that entitlement.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	110496
answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>Claimants of Universal Credit will be entitled to claim help with their National Health Service healthcare travel costs if their earnings for the most recent assessment period are below prescribed thresholds. A claimant would be entitled to claim help with their NHS healthcare travel costs if their earnings during that period were:</p><p>- £435 or less;</p><p>- £935 or less if their Universal Credit includes an element for either:</p><p>- a child; or</p><p>- limited capability for work.</p><p> </p><p>The ‘most recent assessment period’ means the assessment period that ended immediately before the date on which a claimant claimed help with their NHS healthcare travel costs. The period runs for a calendar month.</p><p> </p><p>Where claimants claim Universal Credit as a couple, the earnings threshold that applies is either the earnings of the single claimant or the joint claimants’ combined income.</p><p> </p><p>In addition, where claimants who are in receipt of an element for either a child or limited capacity for work, are responsible for a child, or a young person who is aged over 16 and under 19 who is receiving education or are in a traineeship, those children and young persons will be entitled to claim help with their NHS healthcare travel costs. Individuals aged 18 who are not receiving education and are universal credit claimants in their own right will be entitled to this benefit.</p><p> </p><p>The Department has no current plans to change these arrangements, but will keep the earnings thresholds under review on an annual basis.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:38:32 answering member 4067 label Biography information for Steve Brine
tabling member	163 label Biography information for Sir Stephen Timms

781312

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS Trusts: Vending Machines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department has taken to ensure that sugary snacks are no longer on offer in vending machines in NHS Trust hospitals.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	110539
answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>National Health Service hospitals are required to meet the Government Buying Standards for Food and Catering Services through the NHS Standard Contract, and are required to develop and maintain a food and drink strategy which focuses on healthier eating across the whole hospital community.</p><p> </p><p>NHS England is also taking action on sugar reduction including a voluntary scheme to reduce the sales of sugar sweetened beverages to 10% or less of drinks sales for the whole month of March 2018. Should this prove ineffective, it will ban sales of sugar sweetened beverages from 1 July 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:36:35 answering member 4067 label Biography information for Steve Brine
tabling member	4523 label Biography information for Catherine West

781313

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Leukaemia: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons ibrutinib is not prescribed on the NHS as a treatment for chronic lymphocytic leukaemia.
tabling member constituency	Elmet and Rothwell
tabling member printed	Alec Shelbrooke
uin	110489
answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) published technology appraisal guidance in January 2017 that recommends ibrutinib for the treatment of chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation. Ibrutinib is routinely available to National Health Service patients for these indications in line with NICE’s recommendations if a patient’s doctor considers it to be the most appropriate treatment option.</p><p> </p><p>NICE has not been able to make a recommendation on the use of ibrutinib for use in the treatment of other patients with chronic lymphocytic leukaemia because no evidence submission was received from the product’s manufacturer. Ibrutinib is not therefore routinely commissioned for NHS patients for these other indications. NICE will review this decision if the company decides to make an evidence submission.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:40:07 answering member 4067 label Biography information for Steve Brine
tabling member	3997 label Biography information for Sir Alec Shelbrooke

781369

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Public Health: Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government has taken to assess the (a) cost and (b) economic productivity to the public purse of (i) alcohol misuse, (ii) obesity and (iii) viral hepatitis.
tabling member constituency	East Kilbride, Strathaven and Lesmahagow
tabling member printed	Dr Lisa Cameron
uin	110669
answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Government wants everyone to be able to make healthier choices, regardless of their circumstances, and to minimise the risk and impact of illness. A range of action is being taken to do this and in particular on the three areas identified:</p><p> </p><p>- To tackle alcohol misuse we are preventing below cost selling, tightening the rules on irresponsible promotions and introducing new powers to deal with anti-social behaviour. Local authorities are supported by Public Health England in the commissioning of high quality, evidence based treatment services for their local population’s needs.</p><p>- In addition, the United Kingdom Chief Medical Officers have produced new low risk drinking guidelines which provide the public with the latest information about the health risks of different levels and patterns of drinking. The guidelines enable people to make informed choices about their drinking.</p><p>- Tackling childhood obesity is a priority for this Government. We launched “Childhood Obesity: A Plan for Action” in August 2016. Our world-leading plan will help children and families to recognise and make healthier choices and be more active. Many of the key commitments in our plan will have an impact on tackling obesity across all age groups. These include the soft drinks industry levy and sugar reduction programme, which will reduce the amount of sugar we all consume.</p><p>- A copy of “Childhood Obesity: A Plan for Action” is available at:</p><p><a href="http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/546588/Childhood_obesity_2016__2__acc.pdf" target="_blank">www.gov.uk/government/uploads/system/uploads/attachment_data/file/546588/Childhood_obesity_2016__2__acc.pdf</a></p><p>- The National Strategic Group on Viral Hepatitis is a Public Health England supported, cross-agency expert group on viral hepatitis with external membership from academia, NHS England, local government, clinical commissioning groups, patient representative groups and other organisations, to provide strategic direction and advice around viral hepatitis. The strategy group aims to help reduce the incidence, prevalence and consequences of infection from the viral hepatitis in England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/11/2017 15:05:50 answering member 4067 label Biography information for Steve Brine
tabling member	4412 label Biography information for Dr Lisa Cameron

781407

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to improve the detection of hepatitis B and C.
tabling member constituency	Southend West
tabling member printed	Sir David Amess
uin	110658
answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) guidelines are available to help raise awareness of, and testing for, hepatitis B and C infection in people at increased risk of infection. Screening for hepatitis B and C is recommended in groups who are at increased risk of infection so that diagnosed individuals can be referred for specialist care and management. NICE has also produced best practice guidance on hepatitis B antenatal screening and the new-born immunisation programme. The guidelines can be viewed here:</p><p><a href="https://www.nice.org.uk/guidance/ph43" target="_blank">https://www.nice.org.uk/guidance/ph43</a></p><p>NHS England commissions the infectious diseases in pregnancy screening programme including the screening for hepatitis B, as of part of the maternity pathway. In addition, and as part of health services commissioned for those in the detained settings, NHS England is rolling out an ambitious Opt-Out Blood Borne Viruses (BBV) testing programme; the key aim is to improve uptake rates for hepatitis B and hepatitis C testing by the introduction of good practice for ‘meaningful offer’ of BBV testing across the adult prison estate by end of 2017-18.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/11/2017 14:28:44 answering member 4067 label Biography information for Steve Brine
tabling member	44 label Biography information for Sir David Amess

781408

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome: Health Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to raise awareness of myalgic encephalomyelitis among (a) healthcare professionals and (b) the general public.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	110590
answer	answer is ministerial correction date of answer 08/11/2017 answer text <p>There is information readily available on chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) for both healthcare professionals and the general public via NHS Choices website. Further information is also provided in the National Institute for Health and Care Excellence (NICE) clinical guidance which can be found via their website. This information is provided in formats suitable for both professionals and the public. Both the NHS Choices and NICE guidance can be found at the following links:</p><p><a href="http://www.nhs.uk/conditions/chronic-fatigue-syndrome-cfs/" target="_blank">www.nhs.uk/conditions/chronic-fatigue-syndrome-cfs/</a></p><p><a href="http://www.nice.org.uk/guidance/cg53" target="_blank">www.nice.org.uk/guidance/cg53</a></p><p>On 20 September 2017, NICE announced plans to undertake a full review of the guidance to ensure it reflects the latest available evidence.</p><p>Education and training is also an important feature in building the awareness of clinical professionals. In terms of education and training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the United Kingdom within the context of the National Health Service and is a key part of general practitioner’s qualifying exams.</p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/11/2017 17:07:53 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

781409

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome: Health Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans his Department has to mark International Awareness Day for Chronic Immunological and Neurological Diseases on 12 May 2018.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	110595
answer	answer is ministerial correction date of answer 08/11/2017 answer text <p>There are no specific plans at this point.</p><p> </p><p>NHS England’s Long Term Conditions Unit works with partners such as voluntary sector organisations (including those with a remit on chronic disease) to synchronise communications activity in line with many annual awareness days. The NHS England media team may also provide support through social media to maximise the reach of established campaigns.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/11/2017 17:11:15 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

781411

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what percentage of pharmacies that applied for the Pharmacy Access Scheme payment were deemed eligible for that payment.
tabling member constituency	Barnsley East
tabling member printed	Stephanie Peacock
uin	110672
answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Department applied the criteria for the Pharmacy Access Scheme (PhAS) to all pharmacies in England and published a list of those it deemed eligible in 2016. There were 1,340 pharmacies on this list.</p><p> </p><p>NHS England reviewed, on application, pharmacies that believed there had been an error in drawing up that list; could demonstrate that a physical feature, such as a semi-permanent road block impeded access, meaning that in practice two pharmacies were more than one mile away from each other; or that the pharmacy was 0.8 miles or more from another pharmacy, in an area of high deprivation, and critical for access. Of 356 applications, a further 62 met these review criteria and were subsequently deemed eligible for PhAS payments.</p><p> </p><p>In addition, pharmacies that returned from locally funded arrangements to the national community pharmacy contractual framework from September 2016 to date have been reviewed to determine whether they are eligible. A further 13 pharmacies qualified for PhAS payments via this route.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110673 question first answered 07/11/2017 15:02:08 answering member 4067 label Biography information for Steve Brine
tabling member	4607 label Biography information for Stephanie Peacock

781413

registered interest
date	31/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many additional pharmacies who applied for the Pharmacy Access Scheme payment were deemed eligible for that payment.
tabling member constituency	Barnsley East
tabling member printed	Stephanie Peacock
uin	110673
answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Department applied the criteria for the Pharmacy Access Scheme (PhAS) to all pharmacies in England and published a list of those it deemed eligible in 2016. There were 1,340 pharmacies on this list.</p><p> </p><p>NHS England reviewed, on application, pharmacies that believed there had been an error in drawing up that list; could demonstrate that a physical feature, such as a semi-permanent road block impeded access, meaning that in practice two pharmacies were more than one mile away from each other; or that the pharmacy was 0.8 miles or more from another pharmacy, in an area of high deprivation, and critical for access. Of 356 applications, a further 62 met these review criteria and were subsequently deemed eligible for PhAS payments.</p><p> </p><p>In addition, pharmacies that returned from locally funded arrangements to the national community pharmacy contractual framework from September 2016 to date have been reviewed to determine whether they are eligible. A further 13 pharmacies qualified for PhAS payments via this route.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110672 question first answered 07/11/2017 15:02:08 answering member 4067 label Biography information for Steve Brine
tabling member	4607 label Biography information for Stephanie Peacock